$3\mathrm{.}1$ A major pharmaceutical company, PharmaTech Ltd$.,$ has recently developed a promising new medication that

shows potential in treating a rare but severe genetic disorder. The company has invested significantly in research and

development, involving teams of scientists, researchers, and knowledge workers across multiple departments. The

research findings, clinical trial data, and technical documentation related to the medication are critical and must be

managed carefully.

Question:

Given the importance of the newly developed medication and the need to protect and share knowledge efficiently,

how should PharmaTech Ltd$.$ manage and share the knowledge related to this medication while ensuring that

sensitive information is protected from unauthorized access? $(25)$